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Abstract: 3D tumor spheroids have arisen in the last years as potent tools for the in vitro screening
of novel anticancer therapeutics. Nevertheless, to increase the reproducibility and predictability of
the data originated from the spheroids it is still necessary to develop or optimize the techniques used
for spheroids’ physical and biomolecular characterization. Fluorescence microscopy, such as confocal
laser scanning microscopy (CLSM), is a tool commonly used by researchers to characterize spheroids
structure and the antitumoral effect of novel therapeutics. However, its application in spheroids’
analysis is hindered by the limited light penetration in thick samples. For this purpose, optical
clearing solutions have been explored to increase the spheroids’ transparency by reducing the light
scattering. In this study, the influence of agitation conditions (i.e., static, horizontal agitation, and
rotatory agitation) on the ClearT and ClearT2 methods’ clearing efficacy and tumor spheroids’ imaging
by CLSM was characterized. The obtained results demonstrate that the ClearT method results in the
improved imaging of the spheroids interior, whereas the ClearT2 resulted in an increased propidium
iodide mean fluorescence intensity as well as a higher signal depth in the Z-axis. Additionally, for both
methods, the best clearing results were obtained for the spheroids treated under the rotatory agitation.
In general, this work provides new insights on the ClearT and ClearT2 clearing methodologies and
their utilization for improving the reproducibility of the data obtained through the CLSM, such as
the analysis of the cell death in response to therapeutics administration.
Keywords: ClearT; ClearT2; confocal microcopy; propidium iodide; tumor spheroids
1. Introduction
For the past decades, two-dimensional (2D) cultures (monolayers of cells) of tumor
cells have been the gold standard to develop and evaluate the effectiveness of anticancer
therapeutic agents [1]. Although these 2D cell cultures are cheap and easy to reproduce,
they fail to mimic the tumor tissues’ three-dimensional (3D) architecture, their mechanic
and biochemical properties, as well as their cell-cell and cell-extracellular matrix (ECM)
interactions [1,2]. Up to now, these cell culture models have led to poor predictions of the
therapeutic effectiveness of new therapeutics in humans [3]. To overcome this situation,
3D cell cultures such as spheroids, have emerged as an alternative for drug screening,
before the study proceeds to animal experimentation or to clinical trials in humans [4].
Spheroids are able to represent several properties of the solid tumors, in comparison to
2D cell cultures, such as: (i) distribution of proliferative, senescent and necrotic cells;
(ii) distribution of nutrients and gases, that leads to the formation of hypoxic and acidic
environments; (iii) cell-cell signaling; (iv) ECM deposition; (v) ECM-cell and cell-cell
physical interactions; (v) growth kinetics; (vi) gene expression and (vii) drug resistance
(reviewed in detail in [5]). Despite being a good replica of what happens in real cancerous
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tissue, there is a lack of well-established protocols and equipment adapted to spheroids’
analysis hindering the reproducibility and accuracy of the data originated from these
models, i.e., most of the currently available methods are only optimized for the analysis
of the therapeutics effectiveness on 2D cell cultures [2,6,7]. For instance, the imaging of
spheroids by fluorescence microscopy is quite challenging, namely through confocal laser
scanning microscopy (CLSM). This technique, which is one of the most common and widely
available in the different laboratories worldwide, is used to analyze several features of
the spheroids (e.g., size and morphology [8,9], proteins expression [10], cellular death [11],
and therapeutics or nanoparticles penetration [12]). Nevertheless, since CLSM does not
allow one to fully image samples with a thickness higher than 100–150 µm [13–15], it is
impossible to analyze whole intact spheroids, which usually present diameters superior to
400 µm [16]. Although this problem can be overcome by sectioning the spheroid into thin
slices of 5–7 µm, this procedure is very time-consuming, depend on organic solvent, and
can also compromise the initial structure of the spheroid [13,17]. Therefore, optical clearing
methods have been evaluated to improve the imaging of spheroids by CLSM [18–22].
These methods aim to improve the microscope’s signal penetration depth by increasing the
spheroids transparency and improve the light penetration within the spheroid. For that
purpose, the clearing solutions promote the homogenization of the refractive index (RI)
through the spheroids and reduce the light scattering effect [15,23]. In the literature, several
optical clearing methods have been used for improving the spheroids analysis, namely
ClearT [19], ClearT2 [18,20,21], SeeDB [14,18], FocusClear™ [22], BABB [24–27], Scale [14,18],
CUBIC [28], and CLARITY [29,30]. Among these, ClearT and ClearT2 methods are organic-
solvent and detergent free, the solutions are easy to handle, and the protocols are not very
time-consuming. In ClearT method, samples are cleared by immersing them in increasing
concentrations of aqueous solutions of formamide. The ClearT2 method is performed by
immersing the samples in aqueous solutions with increasing concentrations of formamide
and polyethylene glycol (PEG). PEG is used to maintain the integrity and stability of the
fluorescently-labeled elements (e.g., proteins), thus avoiding the fluorescence quenching
prompted by the formamide [15,31–33]. Both protocols were described for the first time by
Kuwajima et al. to clear mice tissues (e.g., whole brain and brain sections) [32].
In our group, we already demonstrated that ClearT and ClearT2 enhance the imaging
of propidium iodide (PI)-stained spheroids via CLSM [19,21]. However, the influence
of the ClearT and ClearT2 clearing solutions incubation conditions (e.g., static, horizontal
agitation and rotatory agitation) on the spheroids clearing and imaging by CLSM is still
poorly explored in the literature. In most of the studies, the spheroids are maintained
under horizontal agitation during their incubation with the clearing solutions [18,21]. For
instance, Boutin et al. performed the ClearT2 method using a shaker plate at 90 rotations
per minute (RPM) [18]. In other studies, it is not described as the conditions used for the
incubation of the ClearT and ClearT2 [32,34]. In this work, a direct comparison of the ClearT
and ClearT2 methods clearing efficacy was performed taking also in account the influence
of the solutions incubation conditions (static, horizontal agitation, and rotatory agitation)
on the spheroids’ transparency and imaging by CLSM, to determine the best procedure to
obtain improved images of PI-stained spheroids.
2. Materials and Methods
2.1. Materials
Normal human dermal fibroblasts (HFIB) were acquired from PromoCell (Labclinics,
S.A., Barcelona, Spain). T-flasks, cell culture plates and other cell culture consumables were
obtained from ThermoFisher Scientific (Porto, Portugal). Cell imaging plates were bought
from Ibidi GmbH (Ibidi, Munich, Germany). Fetal bovine serum (FBS) was purchased from
Biochrom AG (Berlin, Germany). PI was procured from Invitrogen (Carlsbad, CA, USA).
Agarose was obtained from Grisp (Porto, Portugal). Dulbecco’s modified Eagle’s medium
F12 (DMEM-F12), paraformaldehyde (PFA), phosphate-buffered saline (PBS), trypsin, for-
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mamide (≥99.5%), ethylenediaminetetraacetate (EDTA), and PEG 4000 Da were purchased
from Sigma-Aldrich (Sintra, Portugal).
2.2. Methods
2.2.1. Cells Maintenance and 3D HFIB Formation
HFIB cells were cultured in 175 cm2 T-flasks with DMEM-F12 media supplemented
with FBS (10% (v/v)) and gentamycin and streptomycin (1% (v/v)), inside an incubator
with a humidified atmosphere at 37 ◦C and 5 % CO2 [35]. When cells achieved a confluent
state, they were recovered by using 0.25 % trypsin (1:250) and EDTA 0.1% (w/v). The
spheroids self-assembly on agarose structures with 81 spherical microwells was performed
as previously described in our group [19,21]. In brief, an agarose solution (2% (w/v) in
H2O) was placed on 3-D Petri Dish® templates (Microtissues Inc., Providence, RI, USA)
to obtain the agarose structures. After, these structures were placed in 12-well cell culture
plates and sterilized by ultraviolet (UV) radiation. Then, 1 × 106 HFIB cells were placed in
each structure. During the spheroids’ growth, DMEM-F12 media containing 10% (v/v) of
FBS and 1% (v/v) of streptomycin and gentamycin was added to each well and the plates
were maintained inside an incubator with a humidified atmosphere (37 ◦C and 5% CO2).
The medium was changed every two days.
2.2.2. HFIB Spheroids Fixation and Incubation with PI
After 6 days, spheroids were collected and subjected to a chemical fixation procedure. In
brief, spheroids were immersed on 4% (w/v) PFA during 24 h at 4 ◦C [21]. After, spheroids were
washed with PBS and labeled with PI (1 mL; 10 µg/mL in H2O). After 24 h of PI incubation at
4 ◦C, spheroids were washed three times with PBS to remove the excess of PI staining.
2.2.3. Spheroids Optical Clearing by ClearT
Spheroids that were previously stained with PI were cleared by using the ClearT
solutions [19,32] (Figure 1). Briefly, different formamide solutions (20, 40, 80 and 95% (v/v)
in PBS) were freshly prepared. Then, spheroids were serially incubated with 20, 40, 80
and 95% formamide solutions during 5 min each, and lastly with 95% formamide solution
during 15 min. To assess the best conditions for spheroids’ clearing, spheroids were
immersed in the clearing solutions under three different conditions: (i) static conditions
where no agitation was used—ClearT/S; (ii) horizontal agitation at 200 RPM by using an
orbital mixer (LBX MM1500 series, Labbox, Barcelona, Spain)—ClearT/H; and (iii) rotatory
agitation using a tube roller shaker (MX-T6-S Analog Tube Roller, Scilogex, city, CT, USA)
at 50 RPM—ClearT/R. All the methods were performed at room temperature (RT). After the
clearing, spheroids were transferred to µ-slide 8 well imaging plates (Ibidi GmbH) to be
imaged by CLSM (Section 2.2.6).
Figure 1. Overview of the PI-stained spheroids optical clearing performed through ClearT and ClearT2 using different
spheroids immersion conditions, namely static, horizontal agitation, and rotatory agitation.
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2.2.4. Spheroids Optical Clearing by ClearT2
PI-stained spheroids were cleared by using ClearT2 solutions [21,32]—Figure 1. Initially,
25% formamide/10% PEG 4000 Da and 50% formamide/20% PEG 4000 Da solutions were
freshly prepared, as previously described in detail by Kuwajima [32]. Then, spheroids were
incubated with 25% formamide/10% PEG solution during 10 min, 50% formamide/20%
PEG for 5 min and lastly 50% formamide/20% PEG for 1 h. During the clearing procedure,
three different conditions were tested, as described in Section 2.2.3 for the ClearT method:
(i) ClearT2/S; (ii) ClearT2/H; and (iii) ClearT2/R. All methods were performed at RT. After the
clearing, spheroids were transferred to µ-slide 8 well imaging plates (Ibidi GmbH) to be
imaged via CLSM (Section 2.2.6).
2.2.5. Spheroids Imaging and Analysis by Optical Microscopy
To observe any possible variation in HFIB spheroids transparency and size after each
optical clearing protocol is performed, optical microscopy images of the spheroids were ac-
quired using a CX41 inverted optical microscope (Olympus, Hamburg, Germany) equipped
with an Olympus SP-500 UZ digital camera and an Axio Imager A1 inverted microscope
(Carl Zeiss, SMT, Inc., Oberkochen, Germany) equipped with an AxioVision camera. The
transparency was checked by placing the spheroids on a crosshatched background, as
previously described elsewhere [18,19,21,32]. The influence of the optical clearing methods
on the size of the spheroids was determined by measuring their diameter before and after
the clearing procedure. For this analysis, the optical microscopy images were analyzed by
using an image processing program designed for scientific purposes—ImageJ (National
Institutes of Health, Bethesda, MD, USA) [36], as previously described in detail [35].
2.2.6. Spheroids Imaging and Analysis by CLSM
HFIB spheroids were imaged by CLSM using a Zeiss LSM 710 AxioObserver laser
scanning confocal microscope. For comparative purposes, all the samples were analyzed
using the same equipment settings. The objective used was a 10× air objective (EC Plan-
Neofluar 10×/0.30 M27). The size of the confocal aperture was 1 Airy disk, and z-stacks
were collected with 5 µm intervals. Laser power and master gain were kept constant
during image acquisition. PI was visualized by using 514 nm argon laser and the emission
wavelengths range was 566–719 nm.
The images obtained through CLSM were then analyzed by using ImageJ (National
Institutes of Health [36]), to determine the PI fluorescence levels, imaging depth of the PI
in the Z-axis and PI cross-section imaging depth. The PI fluorescence levels were obtained
by calculating the corrected total cell fluorescence (CTCF) [14,37,38]. For this purpose, the
integrated density (ID), the spheroids area (A) and mean fluorescence of the background
(MFB) values of the CLSM maximum intensity z-projections with a thickness of 100 µm
(total of 20 Z-stacks) were determined and then used in the Equation (1) [19,21,37]:
CTCF = ID − A × MFB (1)
The imaging penetration depth of the PI, i.e., how deep in the Z-axis it is possible to
acquire PI fluorescence signal (please see Figure 4A), was calculated by multiplying the
number of stacks with PI fluorescence (stacks with fluorescence intensity in the spheroids
area higher than the fluorescence intensity of the background) by the thickness of the stack
(5 µm) [39,40]. Lastly, to determine the PI cross-section imaging depth that translates the PI
fluorescence inside the spheroid, it was counted the number of pixels with fluorescence
in the spheroid area at 25, 50, 75 and 100 µm of depth in the Z-axis (please see Figure
4D) [41,42]. To accomplish that, the gray value of each pixel in the spheroid area was
determined (gray value equal to zero corresponds to pixels with no PI fluorescence; gray
value higher than 0 corresponds to pixels with PI fluorescence) [41,42].
The obtained values were compared and normalized to the average of those obtained
for non-cleared spheroids, i.e., maintained in PBS.
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2.2.7. Statistical Analysis
The data obtained were expressed as mean value ± standard deviation (S.D.). The
statistical analysis was performed using one-way analysis of variance (ANOVA) test.
A value of p < 0.05 was considered statistically significant. Data analysis was performed in
GraphPad Prism v.6.0 software (trial version, GraphPad Software, San Diego, CA, USA).
3. Results and Discussion
The optical clearing methods have allowed the obtention of fluorescence microscopy
images of 3D cell cultures with better quality and resolution. Nevertheless, these methods
were initially developed to be applied in tissues or organs gathered from animals and very
few have been optimized for the imaging of spheroids. ClearT and ClearT2 methods have
been already used to clear spheroids in several works [18–21], although these methods
are not yet fully optimized for this purpose. In a previous study performed by our group,
we investigated the influence of PEG molecular weight (4000, 8000 and 10,000 Da) on
the spheroids clearing efficacy of the ClearT2 method [21]. Such study demonstrated
that the utilization of PEG 4000 Da, instead of the conventional PEG 8000 Da, allows
better imaging of spheroids, since it was possible to obtain higher PI mean fluorescence
intensity as well as an increased signal penetration in the Z-axis and fluorescence signal
in the interior of the spheroids [21]. Herein, we further optimized both ClearT and ClearT2
methods taking into consideration the conditions of incubation of the clearing solutions
(Figure 1). For that purpose, PI-stained HFIB spheroids were cleared by using aqueous
solutions of formamide (ClearT) and formamide:PEG 4000 Da (ClearT2) and incubation
under different conditions, namely: (i) static; (ii) horizontal agitation using an orbital mixer;
and (iii) rotatory agitation using a roller shaker. After the clearing and imaging by CLSM,
the spheroids’ size, transparency, PI fluorescence intensity, PI imaging depth in the Z-axis
and PI cross-section imaging were analyzed to determine the best approach to perform the
ClearT and ClearT2 methods.
3.1. Spheroids’ Size
The variations on spheroids’ size are one of the major concerns associated with the
use of the optical clearing methods since it means that the methods affect the sample initial
structure and morphology [15,38]. In some optical clearing methods, organic solvents like
methanol are used for promoting samples dehydration (e.g., Spalteholz’s technique, BABB
and 3DISCO), and these solvents induce spheroids shrinkage [43]. Likewise, methods
that include hydration steps using urea (e.g., Scale and CUBIC) usually induce spheroids
swelling [31]. Theoretically, ClearT and ClearT2 methods may also increase the volume of
the samples, since these methods include the intake of an aqueous clearing solution into the
sample by osmotic pressure [15]. Nevertheless, in previous studies, it was demonstrated
that ClearT and ClearT2 methods do not induce significative changes in the size of animal
samples (e.g., mouse brains) [32] or spheroids [18,19,21]. Similarly, in this study, it was
also observed that the spheroids’ size is not affected by the incubation conditions of the
solutions used in the ClearT and ClearT2 methods (Figure 2 and Table 1). Before the clearing
process, spheroids exhibited mean diameters of 399.04 ± 39.26 µm. After the performance
of the ClearT method under static, horizontal agitation and rotatory agitation conditions, the
mean diameter of the spheroids was 473.23 ± 63.24, 469.90 ± 83.18 and 447.21 ± 13.71 µm,
respectively (Figure 2A). Similar results were obtained for the ClearT2 method, i.e., the
spheroids’ mean diameter was 478.91 ± 67.10, 464.77 ± 42.24 and 474.91 ± 33.43 µm after
using static, horizontal agitation or rotatory agitation conditions, respectively (Figure 2B).
These results demonstrate that the agitation conditions used for the incubation of the
formamide-based solutions will not influence spheroids structure, and therefore it will not
lead to incorrect interpretations [15,38].
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Figure 2. Influence of the immersion conditions used to perform the ClearT (A) and ClearT2 (B) methods on HFIB spheroids
size and transparency. (A,B) represent the spheroids’ diameter after they were cleared with ClearT and ClearT2 methods under
static, horizontal and rotatory agitation, normalized to the average diameter of non-cleared spheroids (388.97 ± 42.94 µm).
Optical transparency of a non-cleared spheroid and spheroids cleared by using ClearT and ClearT2 methods under static,
horizontal agitation, and rotatory agitation conditions (C). Spheroids were imaged on crosshatched backgrounds for the
relative differences in transparency be noticeable. Scale bars correspond to 200 µm. Data are presented as mean ± S.D.;
n = 7, p < 0.05, n.s.—non-significant.
Table 1. Overview of ClearT and ClearT2 application in PI-stained spheroids by using different incubation conditions of the
clearing solutions.









Spheroids’ size (µm) 399.04 ± 39.26 473.23 ± 63.24 469.90 ± 83.18 447.21 ± 13.71 478.91 ± 67.10 464.77 ± 42.24 474.91 ± 33.43
Spheroids’ transparency None Moderate High Very high Moderate High Very High
PI fluorescence (%) a 100 ± 22.94 104.86 ± 39.14 81.71 ± 47.79 59.26 ± 10.38 92.,65 ± 52.56 152.12 ± 33.48 186.93 ± 64.25
PI imaging depth
in the Z-axis (µm) 160.45 ± 16.80 197.14 ± 42.71 208.33 ± 19.92 223.89 ± 37.40 206.82 ± 23.05 214.38 ± 11.48 250.77 ± 16.69
PI cross-imaging depth
at 100 µm in the Z-axis (%) a 100.00 ± 10.66 122.12 ± 13.48 157.80 ± 18.17 183.79 ± 40.14 124.58 ± 26.86 143.00 ± 15.32 155.43 ± 31.74
a: Values normalized to the average of the values obtained for non-cleared spheroids (maintained in PBS).
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3.2. Spheroids’ Transparency
Optical microscopy images of the spheroids placed on a crosshatched background
were acquired to observe if the agitation conditions affect the ClearT and ClearT2 methods
capacity to render transparency to the spheroids [18,19,21,32]. As it is possible to observe
in Figure 2C, independently of the incubation condition of the different formamide-based
solutions, all the cleared spheroids become more transparent when compared to the non-
cleared ones. Notwithstanding, it is possible to witness that the utilization of rotatory
agitation during the spheroids immersion in the clearing solutions, i.e., ClearT/R and
ClearT2/R methods, resulted in the greatest spheroids transparency (Figure 2C).
3.3. PI Fluorescence
It is important to ensure that the optical clearing methods do not impact the fluores-
cence intensity, e.g., quenching. Preservation of the fluorescence will allow the imaging of
the sample through fluorescence microscopy and the correct analysis of the labeled pro-
teins and cellular structures [19]. Methods that include dehydration steps (e.g., BABB and
3DISCO) usually alter the fluorescence of proteins, since protein-based fluorescent chro-
mophores need water molecules to sustain their fluorescence emission [15]. Additionally,
these methods use organic solvents to clear the samples that can induce structural changes
on the fluorescence labelled proteins disrupting their fluorescence [15,44]. Otherwise, it is
also known that the formamide used in ClearT and ClearT2 can mediate the denaturation of
proteins leading to the fluorescence quenching, as previously demonstrated using in vivo
samples stained with the green fluorescent protein (GFP) [32]. With this in mind, ClearT2
method uses PEG simultaneously with formamide to stabilize the proteins, avoiding the
formamide-mediated quenching of the protein dyes fluorescence [32,38].
Considering that the incubation conditions of the ClearT and ClearT2 clearing solutions
resulted in different levels of spheroids transparency, it was also evaluated if the PI fluo-
rescence intensity is influenced by the samples agitation. Therefore, the PI fluorescence
intensity of maximum projections (100 µm) CLSM images of non-cleared and spheroids
cleared by ClearT and ClearT2 under different conditions were measured and are presented
in Figure 3. The obtained images show that the ClearT/S and ClearT/H did not lead to the
loss of PI-fluorescence, while the ClearT/R method reduced the PI fluorescence significantly
to 59.26 ± 10.39% (Figure 3A,C). Such results can be attributed to the DNA denatura-
tion [45] and the quenching of fluorescent dyes [46] by the formamide. Therefore, the
reduction on the PI fluorescence on ClearT/R may show that the rotatory agitation increases
the amount of formamide that interact with the spheroids when compared to the static
and horizontal agitation conditions. Otherwise, the spheroids cleared using the ClearT2/H
and ClearT2/R methods showed a higher PI fluorescence intensity, 152.11 ± 33.48% and
187 ± 64.25%, respectively (Figure 3B,C). Such can be attributed to the increased inter-
action of ClearT2 solutions with the spheroids under agitation conditions, favoring the
stabilization of the PI/DNA staining by PEG as previously reported in the literature [21].
Furthermore, considering that formamide:PEG solutions do not have absorbance in 400–800
nm range, possible autofluorescence phenomena of these solutions should be disregarded,
as previously showed elsewhere [21,47,48].
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Figure 3. Influence of the immersion conditions used to perform the ClearT and ClearT2 on the PI fluorescence intensity in
HFIB spheroids. Fluorescence intensity of PI-stained spheroids after clearing with ClearT (A) and ClearT2 (B) methods under
static, horizontal agitation, and rotatory agitation, normalized to the average of the non-cleared spheroids fluorescence
intensity. Maximum intensity projections CLSM images with a thickness of 100 µm of non-cleared spheroids and spheroids
cleared by ClearT and ClearT2 methods under static, horizontal agitation, and rotatory agitation (C). Scale bars correspond to
200 µm; n = 9, * p < 0.05, n.s.—non-significant.
3.4. PI Fluorescence Depth in Z-Axis
Whole thick samples (like spheroids) are difficult to be fully imaged by CLSM since
the fluorescence signal depth in the Z-axis is very limited. To surpass this limitation, both
ClearT and ClearT2 methods have demonstrated to be capable of increasing the fluorescence
imaging depth in the Z-axis on spheroids [18–21]. The clearing solutions of these methods
homogenize the spheroids overall RI to about 1.44, which leads to a reduction of the light
dispersion and improves the excitation and emission light penetration [15]. The better RI
homogenization, the greater will be the spheroids transparency and then the traveling
of the light throughout the spheroids [33]. Since the transparency of the spheroids is
depended on the procedure used to immerse them on the clearing solutions, this may
also influence the imaging depth of the PI in the Z-axis. To evaluate such effect, the PI
signal depth in the Z-axis was characterized in non-cleared spheroids and those cleared by
ClearT/S, ClearT/H, ClearT/R, ClearT2/S, ClearT2/H and ClearT2/R (Figure 4A–C).
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Figure 4. Influence of the immersion conditions used to perform the ClearT and ClearT2 methods on the PI imaging depth in
the Z-axis and the PI cross-section imaging depth in HFIB spheroids. Schematic representation of the penetration depth
in the Z-axis measured in the spheroids (A). The penetration depth of PI fluorescence signal in the Z-axis of non-cleared
spheroids and spheroids cleared by using ClearT (B) and ClearT2 (C) methods under static, horizontal agitation, and rotatory
agitation conditions. Schematic representation of the PI cross-section imaging depth measured in the spheroids (D).
Cross-section imaging depth of PI fluorescence signal of spheroids cleared by using ClearT (E) and ClearT2 (F) methods
under static, horizontal agitation, and rotatory agitation conditions, normalized to the average of the non-cleared spheroids
values. Cross-section CLSM images of non-cleared and cleared spheroids by using ClearT and ClearT2 methods under static,
horizontal and rotatory agitation conditions (G). Scale bars correspond to 200 µm; n = 9, * p < 0.05, n.s.—non-significant.
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The attained results showed that both optical clearing methods allowed to acquire
fluorescence at deeper distances in the Z-axis (Figure 4B,C). Such effect was more pro-
nounced when the spheroids were immersed in the clearing solutions under horizontal
and/or rotatory agitation. In comparison to the non-cleared spheroids, it was possible to
obtain more 29.84 ± 12.41% and 39.53 ± 23.31% PI signal in the Z-axis after the spheroids
being cleared by ClearT/H and ClearT/R, respectively (Figure 4B), and more 33.60 ± 7.15%
and 56.60 ± 10.40% when the ClearT2/H and ClearT2/R methods were used, respectively
(Figure 4C). These results are in agreement with those previously obtained and demon-
strate that the use of agitation improves the penetration of the clearing solutions into the
spheroids, allowing a better RI homogenization and then a higher spheroids transparency
and detection of the fluorescence signal at higher depths in the Z-axis.
3.5. Spheroids Cross-Section Imaging
The acquisition of fluorescence inside the spheroids is very important for therapeutics
research purposes. For instance, the imaging of the interior of the spheroids with a fluores-
cence microscope is crucial to evaluate the dispersion of pharmaceuticals or nanoparticles
within the spheroids [49–51], as well as to analyze the cellular death and the expression
of proteins before and after therapeutics administration [52–54]. Nevertheless, the light
scattering and its dispersion through the sample hinder the imaging of the spheroids’ inte-
rior [18]. Therefore, the cross-section imaging depth in the PI-stained spheroids subjected
to ClearT and ClearT2 methods was performed to determine the best incubation conditions.
For that purpose, the number of pixels with PI signal inside the spheroids at different
depths in Z-axis (25, 50, 75 and 100 µm) was measured [41,42]—Figure 4D.
The obtained results showed that both ClearT and ClearT2 methods allowed to obtain a
higher PI fluorescence inside the spheroids when compared to the non-cleared spheroids
(Figure 4E–G), being this difference noticeable at 100 µm in the Z-axis. Moreover, the use
of agitation during the spheroids incubation with the clearing solutions was one more
time crucial to improve the imaging of the interior of the spheroids. In fact, at 100 µm
in the Z-axis, the ClearT/H and ClearT2/H methods allowed to obtain more 57.80 ± 18.17%
and 43.00 ± 15.32% of PI signal inside the spheroids, whereas the ClearT/R and ClearT2/R
enhanced the PI signal in 83.79 ± 40.14% and 55.43 ± 31.74%, respectively (Figure 4E,F).
Moreover, the CLSM images presented in Figure 4G further support these results, be-
ing observed PI-stained cells within deeper regions of the spheroids at a penetration
depth of 100 µm when horizontal or rotatory agitation conditions were used, which con-
trasts with more localize PI fluorescence in the most external layers of the non-cleared
or cleared by ClearT/S and ClearT2/S spheroids. Interestingly, the ClearT method allowed
to obtain more PI signal inside the spheroids in comparison to those cleared through the
ClearT2 method (Figure 4E–G). Such result may be explained by an easier entrance of the
formamide-aqueous solutions into the spheroids’ interior, since these are less viscous than
the formamide/PEG solutions used in the ClearT2 method.
4. Conclusions
The potential of spheroid tumor models for the in vitro screening of novel anticancer
therapeutic approaches was already demonstrated in the literature. Nevertheless, the
methods and equipment for extracting data from these models still need to be optimized
for application in spheroids. In this field, different studies have been demonstrating that
optical clearing methods are crucial for the imaging and analysis of whole spheroids,
avoiding the sample sectioning. In this work, the clearing efficacy of ClearT and ClearT2
optical clearing methods and the influence of the incubation conditions of their solutions
(static, horizontal agitation, and rotatory agitation) have on the imaging of PI-stained
spheroids by CLSM were analyzed (Table 1). Both ClearT and ClearT2 methods can be used
to prompt transparency on the spheroids, without affecting their size. ClearT demonstrated
to be the best method to image the spheroids’ interior, while ClearT2 allowed to achieve
a greater PI fluorescence intensity and a higher PI signal depth in the Z-axis. In both
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methods, the use of agitation during the spheroids immersion in the clearing solutions
resulted in improved imaging of the PI fluorescence in the spheroids, principally when
rotatory agitation was employed.
Overall, this article contributes to increasing the amount and accuracy of the data
extracted from spheroid models. Additionally, the obtained data can assist other researchers
to further optimize the optical clearing methods that will enhance the imaging of whole
spheroids. Such is crucial for supporting the application of these models in pharmaceutical
research and industry, for instance, to monitor by fluorescence microscopy the cellular
death in spheroids prompted by novel anticancer therapeutics.
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